KR100690240B1 - Intermediate compound for ubiquinone and manufacturing method of the same - Google Patents

Intermediate compound for ubiquinone and manufacturing method of the same Download PDF

Info

Publication number
KR100690240B1
KR100690240B1 KR1020050109623A KR20050109623A KR100690240B1 KR 100690240 B1 KR100690240 B1 KR 100690240B1 KR 1020050109623 A KR1020050109623 A KR 1020050109623A KR 20050109623 A KR20050109623 A KR 20050109623A KR 100690240 B1 KR100690240 B1 KR 100690240B1
Authority
KR
South Korea
Prior art keywords
compound
ubiquinone
formula
group
compound represented
Prior art date
Application number
KR1020050109623A
Other languages
Korean (ko)
Inventor
최원식
장도연
신현창
어진용
Original Assignee
최원식
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 최원식 filed Critical 최원식
Priority to KR1020050109623A priority Critical patent/KR100690240B1/en
Application granted granted Critical
Publication of KR100690240B1 publication Critical patent/KR100690240B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

An intermediate compound for preparing ubiquinone and a method for preparing thereof are provided to be able to obtain ubiquinone with high yield and high quality through simple product purification process at relatively cheap cost. The method for preparing a compound represented by the formula(II) or a compound represented by the formula(III) comprises a step of reacting a compound represented by the formula(IV) or a compound represented by the formula(V) with a silylating compound such as trimethylchlorosilane, hexamethyldisilazane, and N,O-bis(trimethylsilyl)acetamide in the presence of an organic polar solvent such as CH2Cl2, 1,2-dichloroethane, acetonitrile and dimethylformamide so as to protect OH group of hydroquinone in the compound of the formula(IV) or the compound of the formula(V). In the formulae, R is alkyl or alkoxy, Z is H or halogen, Y is H, benzene sulfonyl or toluene sulfonyl, and n is an integer from 0 to 9.

Description

유비퀴논 제조용 중간체 화합물 및 그의 제조방법{Intermediate compound for ubiquinone and manufacturing method of the same}Intermediate compound for ubiquinone and manufacturing method of the same

본 발명은 다음 구조식(Ⅰ)로 표시되는 유비퀴논(Ubiquinone) (코엔자임Q10(CoenzymeQ10)이나 유비데카레논(Ubidecarenone)으로도 명명되는 화합물)을 제조하는데 유용한 새로운 중간체 화합물들과 이들의 제조방법에 관한 것이다. 구체적으로는 다음 일반식(Ⅳ) 또는 (Ⅴ)로 표시되는 화합물에서 파라-하이드로퀴논의 -OH기가 실릴 화합물(silyl compound)로 보호된 다음 일반식(Ⅱ)와 (Ⅲ)으로 표시되는 유비퀴논 제조용 중간체 화합물에 관한 것이다. The invention ubiquinone (Ubiquinone) useful new intermediate compounds for the production of (Coenzyme Q 10 (CoenzymeQ 10) or ubiquinone deca-fluorenone (Ubidecarenone) by also named compound) and methods for their preparation are shown in the following structural formula (Ⅰ) It is about. Specifically, in the compound represented by the following general formula (IV) or (V), the -OH group of para-hydroquinone is protected by a silyl compound and then ubiquinone represented by the general formulas (II) and (III). It relates to an intermediate compound for preparation.

Figure 112005065891716-pat00003
Figure 112005065891716-pat00003

Figure 112005065891716-pat00004
Figure 112005065891716-pat00004

Figure 112005065891716-pat00005
Figure 112005065891716-pat00005

상기식들에서 R은 알킬 또는 알콕시기이며 Z는 수소, 또는 할로겐이며, Y는 수소, 벤젠설포닐 또는 톨루엔 설포닐기이며 n은 0∼9의 정수이다.Wherein R is an alkyl or alkoxy group, Z is hydrogen or halogen, Y is hydrogen, benzenesulfonyl or toluene sulfonyl group and n is an integer from 0 to 9.

일반식(Ⅳ) 또는 (Ⅴ)로 표시되는 화합물은 상기 일반식 (Ⅱ) 또는 (Ⅲ)으로 나타낸 바와 같이 -OH기를 보호기인 실릴화합물로 보호시켜 용이하게 유비퀴논으로 전환 시켜줄 수 있다.The compound represented by formula (IV) or (V) can be easily converted to ubiquinone by protecting the -OH group with a silyl compound as a protecting group, as represented by formula (II) or (III).

상기 일반식(Ⅱ)에서 R이 메틸기이고 Z가 수소인 화합물은 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)톨루엔으로 명명될 수 있다.In the general formula (II), a compound in which R is a methyl group and Z is hydrogen may be named 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) toluene.

또한 R이 메틸기이고, Z가 브롬인 화합물은 6-브롬-3,4-디메톡시-2,5-비스(트리메틸실릴옥시)톨루엔으로 명명될 수 있다.In addition, compounds in which R is a methyl group and Z is bromine may be named 6-bromine-3,4-dimethoxy-2,5-bis (trimethylsilyloxy) toluene.

상기 일반식(Ⅲ)에서 R이 메틸기이고 Y가 수소이며 n=0인 화합물은 3,4-디메 톡시-2,5-비스(트리메틸실릴옥시)-6-이소프레닐톨루엔으로 명명될수 있으며 n=9인 화합물은 유비퀴논으로 명명되고 있다.In the general formula (III), a compound in which R is a methyl group, Y is hydrogen and n = 0 may be named 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6-isoprenyltoluene and n The compound with = 9 is named ubiquinone.

Y가 벤젠설포닐이며 n=0인 화합물은 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(이소프레닐-4-벤젠설포닐)톨루엔으로 명명될 수 있으며 n=9인 화합물은 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(데카프레닐-4-벤젠설포닐)톨루엔으로 명명될 수 있다.A compound wherein Y is benzenesulfonyl and n = 0 can be named 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (isoprenyl-4-benzenesulfonyl) toluene and n A compound with = 9 may be named 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (decaprenyl-4-benzenesulfonyl) toluene.

Y가 톨루엔 설포닐이며 n=0인 화합물은 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(이소프레닐-4-톨루엔설포닐)톨루엔으로 명명될 수 있으며 n=9인 화합물은 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(데카프레닐-4-톨루엔설포닐)톨루엔으로 명명될 수 있다.A compound wherein Y is toluene sulfonyl and n = 0 can be named 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (isoprenyl-4-toluenesulfonyl) toluene and n A compound with = 9 may be named 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (decaprenyl-4-toluenesulfonyl) toluene.

유비퀴논은 소의 심장에서 발견된 화합물로 동물의 생체 내 존재하는 매우 중요한 생리활성물질로 알려져 있다. 유비퀴논은 인체의 모든 세포에서 발견되며 혈장에 약 0.1-1 μmole/ℓ정도가 들어 있으며. 심장, 간, 신장 및 췌장에 존재하는 물질로 호흡을 통한 전자 전달계의 산화-환원 반응에 참여하며 세포내의 미토콘드리아(mitochondria)에서 생명체에 에너지를 공급해 주는 역할을 하는 중요한 생리활성 물질이다. 또한 유비퀴논(코엔자임Q10)은 심혈관계 질환인 심장병, 고혈압, 당뇨, 노화방지와 암예방 등에 효과가 있다는 사실이 밝혀졌으며, 주름살 개선, 미백과 자외선 차단 효과 등으로 인해 화장품으로도 널리 사용되고 있다. 이러한 화합물들은 음식으로 섭취하거나 체내에서 합성되어야하는데, 질병이 있거나 나이가 많은 사람들은 체내합성량이 급격히 감소되어 외부에서 공급을 받아야 하기 때문에 유비퀴논(코엔자임Q10)은 전 세계적으로 사용양이 급격히 증가하게 되었으며 이 화합물의 제조방법에 대한 많은 연구들이 진행되고 있는 실정이다.Ubiquinone is a compound found in bovine heart and is known as a very important bioactive substance present in animals. Ubiquinone is found in all cells of the body and contains about 0.1-1 μmole / ℓ in plasma. It is a substance present in the heart, liver, kidney and pancreas. It is an important physiologically active substance that participates in the oxidation-reduction reaction of the electron transport system through respiration and provides energy to life in mitochondria in cells. In addition, ubiquinone (coenzyme Q 10 ) has been found to be effective in cardiovascular diseases such as heart disease, high blood pressure, diabetes, anti-aging and cancer prevention, and is widely used in cosmetics due to wrinkle improvement, whitening and sun protection. . These compounds must be consumed by food or synthesized in the body. Ubiquinone (coenzyme Q 10 ) is rapidly increasing in use worldwide because diseased or older people need to be supplied externally due to a sharp decrease in their synthesis. And many studies on the preparation method of this compound is in progress.

유비퀴논(코엔자임Q10)의 제조 방법은 크게 발효법과 합성법이 있으며 발효법은 일본업체에서 주로 채택하고 있다. The production method of ubiquinone (coenzyme Q 10 ) is largely a fermentation method and a synthesis method, and the fermentation method is mainly adopted by Japanese companies.

합성법에 의한 제조방법으로는 다음과 같은 방법이 알려져 있다. 첫째, 아래 화학반응식으로 표시된 바와 같이 데카프레닐 브로마이드(Decaprenyl bromide)와 리튬트리메틸틴(lithium trimethyltin)을 반응시켜서 얻어지는 반응물에 6-브로모-2,3-디메톡시-5-메틸-1,4-벤조퀴논 (6-bromo-2,3- dimethoxy -5-methyl-1,4-benzoquinone)을 반응시켜 유비퀴논을 합성하는 방법이 있다.(J. org . chem., 45, 4097(1980)) 이 방법의 결점은 데카프레닐 브로마이드의 제조가 어려우며 리튬트리메틸틴이 매우 고가이므로 유비퀴논 제조시 원가가 매우 높아진다는 문제가 있다.The following method is known as a manufacturing method by the synthesis method. First, 6-bromo-2,3-dimethoxy-5-methyl-1,4 to a reactant obtained by reacting decaprenyl bromide with lithium trimethyltin, as shown by the chemical equation below. - benzoquinone (6-bromo-2,3- dimethoxy -5 -methyl-1,4-benzoquinone) was reacted by a method of synthesizing ubiquinone (J. org chem, 45, 4097 (1980)... The drawback of this method is that it is difficult to produce decaprenyl bromide and the cost of producing ubiquinone is very high because lithium trimethyltin is very expensive.

Figure 112005065891716-pat00006
Figure 112005065891716-pat00006

상기 반응식에서 Me는 메틸기를, THF는 테트라하이드로퓨란(tetrahydrofuran)을 나타낸다.Me represents a methyl group and THF represents tetrahydrofuran.

둘째, 미국특허 6506915에는 다음 반응식으로 나타낸 바와 같이 2,3,4,5-테트라메톡시톨루엔(2,3,4,5-tetramethoxytoluene)으로부터 2,3,4,5-테트라메톡시-6-게라닐톨루엔(2,3,4,5-tetramethoxy-6-geranyltoluene)을 제조한 후 6,7-에폭시게라닐-2,3,4,5-테트라메톡시톨루엔(6,7-epoxygeranyl-2,3,4,5- tetramethoxytoluene )을 제조하고 디이소프로필(4E)-1-이소프로페닐-4-메틸- 6-(2,3,4,5-테트라메톡시톨루엔-4-헥세닐)포스페이드(diisoprpyl(4E)-1-isopropenyl-4-methyl-6-(2,3,4,5-tetramethoxytoluene-4-hexenyl phosphate)를 제조하여 게라닐게라닐 마그네슘 브로마이드(geranylgeranyl magnesium bromide)와 반응시켜 측쇄(side chain)의 탄소수를 30개인 화합물을 제조하고 이 화합물에 탄소수가 20개인 이소프레노이드(isoprenoid) 계 화합물을 여러 단계를 거쳐 제조하는 방법이다. 그러나 이 방법은 제조공정이 복잡하고 따라서 생산비용이 높아진다는 문제가 있다.Second, US Patent 6506915 discloses 2,3,4,5-tetramethoxy-6- from 2,3,4,5-tetramethoxytoluene as shown in the following scheme. Geranyltoluene (2,3,4,5-tetramethoxy-6-geranyltoluene) was prepared and then 6,7-epoxygeranyl-2,3,4,5-tetramethoxytoluene (6,7-epoxygeranyl-2 , 3,4,5-tetramethoxytoluene) was prepared and diisopropyl (4E) -1-isopropenyl-4-methyl-6- (2,3,4,5-tetramethoxytoluene-4-hexenyl) Phosphate (diisoprpyl (4E) -1-isopropenyl-4-methyl-6- (2,3,4,5-tetramethoxytoluene-4-hexenyl phosphate) was prepared and reacted with geranylgeranyl magnesium bromide To prepare a compound having 30 carbon atoms in the side chain, and to prepare an isoprenoid compound having 20 carbon atoms in the compound through several steps. Production cost There is a problem of being high.

Figure 112005065891716-pat00007
Figure 112005065891716-pat00007

셋째, 미국특허 3896153에는 다음 반응식으로 나타낸 바와 같이 6-브로모-2,3,4,5-테트라메톡시톨루엔(6-bromo-2,3,4,5-tetramethoxytoluene)과 데카프레닐 브로마이드(decaprenyl bromide)를 니켈카르보닐(Ni(CO)4)과 반응시켜 여러단계를 거쳐 유비퀴논을 합성하는 방법에 대하여 기재하고 있다. 그러나 이 제조방법 역시 데카프레닐 브로아미드를 제조하기가 어려우며 정제과정이 매우 복잡하여 수율이 매우 낮은 단점이 있다. Third, U.S. Patent 3896153 discloses 6-bromo-2,3,4,5-tetramethoxytoluene and decaprenyl bromide (6-bromo-2,3,4,5-tetramethoxytoluene) as shown in the following scheme. It describes a method for synthesizing ubiquinone through several steps by reacting decaprenyl bromide with nickel carbonyl (Ni (CO) 4 ). However, this manufacturing method is also difficult to produce decaprenyl broamide, and the purification process is very complicated, the yield is very low.

Figure 112005065891716-pat00008
Figure 112005065891716-pat00008

넷째, 미국특허 4062879에는 다음 반응식으로 나타낸 바와 같이 2-하이드록시-3,4,5-트리메틸톨루엔(2-hydroxy-3,4,5-trimethoxytoluene)과 수산화붕소〔B(OH)3〕를 반응시켜 2번 위치의 -OH기를 보론화합물로 보호시킨후 데카프레닐 브로마이드와 반응시켜 6번위치에 데카프레닐기(decarprenyl group)가 도입된 화합물을 제조한후 보호기를 제거하고 FeCl3ㅇ6H2O로 환원시켜 유비퀴논을 제조하는 방법이 기재되어 있다.Fourth, US Pat. No. 40,628,79 reacts 2-hydroxy-3,4,5-trimethyltoluene with boron hydroxide [B (OH) 3 ] as shown in the following scheme. To protect the -OH group at position 2 with a boron compound, react with decaprenyl bromide to prepare a compound having a decarprenyl group introduced at position 6, remove the protecting group, and remove FeCl 3 -6H 2 O. A method of preparing ubiquinone by reduction with is described.

Figure 112005065891716-pat00009
Figure 112005065891716-pat00009

최근에는 다음 반응식과 같이 다음 구조식(Ⅵ)의 3,4-디메톡시-2,5-디알킬메틸-6-(이소프레닐-4-벤젠설포닐)톨루엔 또는 3,4-디메톡시-2,5-디알콕시메틸-6-(이소프레닐-4-벤젠설포닐)톨루엔과 담배 잎에서 추출한 솔라네솔의 -OH기를 브롬화시킨 솔라네실 브로마이드를 반응시켜 하기 일반식(Ⅶ)로 표시되는 화합물을 제조하고, 여기에서 보호기를 제거하여 유비퀴논을 제조하는 방법을 많이 이용하고 있다.(참고문헌 J. O. Chem., 2003, 68, 7925, Bull. Chem. Soc., Jpn., 1982, 55, 1325, Synthesis, 1981, 469)Recently, 3,4-dimethoxy-2,5-dialkylmethyl-6- (isoprenyl-4-benzenesulfonyl) toluene or 3,4-dimethoxy-2 of the following structural formula (VI) Compound represented by the following general formula by reacting, 5-dialkoxymethyl-6- (isoprenyl-4-benzenesulfonyl) toluene with solanesyl bromide brominated -OH group of solanesol extracted from tobacco leaves And ubiquinone by removing a protecting group therefrom. (References JO Chem ., 2003, 68, 7925, Bull. Chem. Soc., Jpn ., 1982, 55, 1325) , Synthesis, 1981, 469)

Figure 112005065891716-pat00010
Figure 112005065891716-pat00010

여기서 R기는 알킬, 알콕시메틸, 벤질기 등이다.R group is an alkyl, alkoxymethyl, benzyl group, etc. here.

최근 유비퀴논을 제조하는 방법으로는 상기 일반식(Ⅳ)로 표시되는 화합물에서 Z가 이소프레닐-4-벤젠설포닐기인 화합물의 OH기를 보호하여 일반식(Ⅵ)인 화합물을 제조한 후 솔라네실기를 도입시켜 제조하는 공정이 간단하고 경제적으로 경쟁력이 있어 많이 이용되고 있다.Recently, a method for preparing ubiquinone includes preparing a compound of Formula (VI) by protecting the OH group of a compound represented by Formula (IV), wherein Z is isoprenyl-4-benzenesulfonyl group. The manufacturing process by introducing the nesil group is simple and economically competitive, and is widely used.

이 경우 유비퀴논 제조용 중간체에서 파라-하이드로퀴논 화합물의 2,5위치의 -OH기를 보호기로 보호하여주는 것은 매우 중요하다. 유비퀴논을 합성하는 공정에서 -OH기를 보호하지 않으면 부반응이 진행되어 수율이 매우 낮아지거나 최종목적물인 유비퀴논을 얻기가 어려워 진다. 따라서, 보호기의 선택이 최종목적물을 생산하는 생산원가와 품질을 결정하는 중요한 요인이 된다. 즉, 보호기인 R을 도입하는 과정에서 생산 수율이 높아야하며 반응 후 보호기를 쉽게 제거 할 수 있는 작용기를 선택하여야 한다.In this case, it is very important to protect the -OH group at the 2,5-position of the para-hydroquinone compound with a protecting group in the intermediate for preparing ubiquinone. In the process of synthesizing ubiquinone, if the -OH group is not protected, a side reaction proceeds and the yield becomes very low, or it is difficult to obtain the final target ubiquinone. Therefore, the selection of the protector is an important factor in determining the production cost and quality of producing the end object. That is, the production yield should be high in the process of introducing R, a protecting group, and a functional group that can be easily removed after the reaction should be selected.

종래 상기 구조식(Ⅵ)로 표시되는 화합물에서 파라-하이드로퀴논의 -OH기를 보호하기 위해 주로 사용한 시약으로는 메틸할라이드, 벤질할라이드, 할로메틸알킬에테르, 할로메틸알콕시에틸에테르, 알콕시비닐에테르, 디알콕시메탄등을 주로 사용하였다. 그러나, 이들 시약들은 고가이고 -OH기를 보호하는데 이들 시약들을 과량 사용하여야 반응이 진행되며, 알킬할라이드나 벤질 할라이드의 경우 염기로 소디움 알콕사이드 등을 함께 사용하며, 할로메틸 알킬에테르, 할로메틸 알콕시 에틸에테르, 알콕시 비닐에테르나 디알콕시메탄등은 산성 촉매를 사용하지 않으면 반응이 진행 진행되지 않는다. 이때 사용되는 산성촉매 역시 산성을 갖는 유기산으로 예를들면 피리디니움파라톨루엔설포네이트(pyridinium p-toluenesulfonate)나 Nafion-H등의 고가의 촉매를 사용한다. 또한, 이 반응에서 2개의 OH기가 모두 보호되어야 하는 데 이들 시약을 사용할 경우 한쪽 OH기만 보호되는 화합물이 불순물로 만들어져 순도가 80-85%정도로 낮으며 반응수율도 저하된다. 또한 부반응 생성물이 여러 종류가 생성되므로 순수하게 정제하는데 많은 어려움이 있다.Reagents mainly used to protect the -OH group of para-hydroquinone in the compound represented by the above structural formula (VI) include methyl halide, benzyl halide, halomethyl alkyl ether, halomethylalkoxyethyl ether, alkoxy vinyl ether, dialkoxy Methane and the like were mainly used. However, these reagents are expensive and the reaction proceeds only when the reagents are used excessively to protect the -OH group. In the case of alkyl halides or benzyl halides, sodium alkoxides are used as bases, and halomethyl alkyl ethers and halomethyl alkoxy ethyl ethers are used. , Alkoxy vinyl ether or dialkoxymethane does not proceed unless the acidic catalyst is used. The acid catalyst to be used, too, for example an organic acid having an acid uses an expensive catalyst such as pyridinium p-toluene sulfonate nium (pyridinium p -toluenesulfonate) and Nafion-H. In addition, in this reaction, both OH groups should be protected. When these reagents are used, compounds that protect only one OH group are made of impurities, resulting in low purity of 80-85% and lowering reaction yields. In addition, since there are many kinds of side reaction products, there are many difficulties in pure purification.

또한, 화합물(Ⅶ)을 제조한후 벤젠설포닐기를 제거시킨후 OH기의 보호기를 제거하여 유비퀴논(코엔자임Q10)을 제조하는 공정에서 보호기가 알킬 또는 벤질기인 경우 암모늄세륨(IV)나이트레이트(ammonium cerium(Ⅳ) nitrate)등을 사용하여야 하며 이때 수득율이 50-60%로 매우 낮다. 또한, 할로메틸알킬에테르, 할로메틸알콕시에테르, 알콕시비닐에테르나 디알콕시메탄등을 사용할 경우도 보호기를 제거하는 과정에서 반응시간이 길고 강산을 사용하여야 하는등 이 과정에서 수득율이 낮으며 여러 가지 불순물들이 생성되고 정제를 위해 실리카겔 크로마토 그래피 방법을 사용해야 하기 때문에 정제과정이 복잡해진다. 이러한 이유로 인하여 제품의 생산단가를 상승시키는 요인이 되었다. In addition, in the process of preparing ubiquinone (coenzyme Q 10 ) by removing a benzenesulfonyl group after preparing compound (iii) and then removing a protecting group of OH group, ammonium cerium (IV) nitrate when the protecting group is alkyl or benzyl group (ammonium cerium (Ⅳ) nitrate) should be used, and the yield is very low, 50-60%. In addition, in case of using halomethyl alkyl ether, halomethyl alkoxy ether, alkoxy vinyl ether or dialkoxymethane, the reaction time is long in the process of removing the protecting group, and the yield is low in this process due to the use of strong acid. Purification is complicated because they are produced and the silica gel chromatography method must be used for purification. For this reason, it is a factor that increases the production cost of the product.

이상 설명한 바와 같이 종래 합성법으로 유비퀴논을 제조하는 방법에서는 상기 일반식(Ⅲ)으로 표시되는 파라-하이드로퀴논 화합물을 메틸할라이드, 벤질할라이드, 할로메틸알킬에테르, 알콕시비닐에테르, 디알콕시메탈 또는 보론화합물〔B(OH)3〕과 반응시켜 파라-하이드로퀴논 화합물의 -OH기를 알킬, 알콕시, 벤질, 보론 등으로 보호시키거나 소디움알콕사이드와 같은 염기나 피리디니움파라톨루엔 설포네이트, Nafion-H를 사용하여 시럽상태로 순도가 80-85%정도인 상기 일반식(Ⅵ) 으로 표시되는 화합물을 제조하고 이 화합물(Ⅵ)과 솔라네실 브로아미드를 반응시켜 솔라네솔기를 도입하여 상기 일반식(Ⅶ)로 표시되는 화합물을 제조하고 벤젠설포닐기로 보호된 OH기의 보호기를 제거하기 위하여 암모늄세륨나이트레이트 촉매를 사용하거나 강산을 이용하여 복잡한 정제과정을 거쳐 유비퀴논을 합성하였다.As described above, in the method for preparing ubiquinone by the conventional synthesis method, the para-hydroquinone compound represented by the general formula (III) may be methyl halide, benzyl halide, halomethyl alkyl ether, alkoxy vinyl ether, dialkoxy metal or boron compound. React with [B (OH) 3 ] to protect the -OH group of the para-hydroquinone compound with alkyl, alkoxy, benzyl, boron, etc., or use a base such as sodium alkoxide, pyridinium paratoluene sulfonate, or Nafion-H. To prepare a compound represented by the general formula (VI) having a purity of about 80-85% in a syrup state, and reacting the compound (VI) with solanesil broamide to introduce a solanesol group to In order to prepare the compound represented by the formula and to remove the protecting group of the OH group protected by the benzenesulfonyl group, an ammonium cerium nitrate catalyst or The ubiquinone was synthesized through a complicated purification process.

그러나, 상기한 방법들은 이미 언급한 바와 같이 파라-하이드로퀴논의 -OH기에 보호기를 도입시켜줄 때 고가의 촉매를 사용하여야 하며 일반식(Ⅵ)로 표시되는 화합물의 불순물 생성 및 수율저하와 화합물(Ⅵ)과 솔라네실 브로마이드를 반응시킨 화합물(Ⅶ)을 제조하여 벤젠설포닐기를 제거하고 OH기의 보호기 제거 공정에서 강산을 사용하므로서 여러 가지 다양한 부산물이 생성되고 이들 불순물을 제거하기 위해서 실리카겔 크로마토그래피법 등을 적용함으로 인해 수율이 낮아지게 된다는 문제가 있다.However, the aforementioned methods should use an expensive catalyst when introducing a protecting group to the -OH group of para-hydroquinone, and impurity formation and yield reduction of the compound represented by formula (VI) and compound (VI). ) And solanesyl bromide were prepared to remove benzenesulfonyl group, and strong acid was used in OH group protecting group removal process to produce various various by-products and to remove these impurities. There is a problem that the yield is lowered by applying.

본 발명에서는 일반식(Ⅳ)로 표시되는 화합물과 일반식(Ⅴ)로 표시되는 화합물에서 OH기를 보호하는데 N,O-비스(트리메틸실릴)아세트아마이드(N,O-bis(trimethylsilyl)acetamide), 트리메틸클로로실란, 헥사메틸디실라잔(hexamethyldisilazane)등을 사용하여 2개의 OH기가 쉽게 실란화합물로 보호된 상기 일반식(Ⅱ)와 (Ⅲ)으로 표시되는 화합물을 얻을 수 있다.The general formula (Ⅳ) compound and formula (Ⅴ) to protect OH group in the compound represented by N, O represented by the invention-bis (trimethylsilyl) acetamide (N, O -bis (trimethylsilyl) acetamide), Using trimethylchlorosilane, hexamethyldisilazane and the like, compounds represented by the above general formulas (II) and (III) in which two OH groups are easily protected with a silane compound can be obtained.

본발명의 목적은 유비퀴논제조용 새로운 중간체 화합물과 이들의 제조방법을 제공하는데 있다.It is an object of the present invention to provide novel intermediate compounds for the preparation of ubiquinones and methods for their preparation.

구체적으로는 상기 일반식(Ⅳ)와 (Ⅴ)로 표시될 수 있는 파라-하이드로퀴논 화합물을 중간체로 하여 유비퀴논을 합성하는 방법에 있어서, 파라-하이드로퀴논 화합물의 -OH기를 실릴화합물로 보호한 상기 일반식(Ⅱ) 및 일반식(Ⅲ)으로 표시되는 유비퀴논 제조용 중간체 화합물과 이들의 제조방법을 제공하는데 있다.Specifically, in the method for synthesizing ubiquinone by using the para-hydroquinone compounds represented by the general formulas (IV) and (V) as an intermediate, the -OH group of the para-hydroquinone compound is protected by a silyl compound. It is to provide an intermediate compound for producing ubiquinone represented by the general formulas (II) and (III) and a method for producing the same.

본발명의 유비퀴논 제조용 중간체들은 높은 수율과 낮은 비용으로 제조가 가능하며, 간단한 방법으로 보호기를 제거하여 유비퀴논을 제조할 수 있는 특징을 갖는다.Intermediates for producing ubiquinone of the present invention can be manufactured in high yield and low cost, and has the characteristic of preparing ubiquinone by removing a protecting group by a simple method.

또한 실란으로 보호된 일반식(Ⅲ)으로 표시되는 화합물과 솔라네실 브로마이드를 반응시킨후 OH기를 보호하기 위해 도입한 실란화합물을 제거하는데 염산수용액에서 쉽게 제거 할수 있는 장점이 있다. 이 제조 방법을 이용할 경우 최종 목적물의 유비퀴논 제조시 불순물이 거의 없이 제조되므로 정제과정이 매우 간단하게 되며 크로마토그래피법의 정제 방법을 이용하지 않아도 제품을 높은 수율과 고순도로 제조할 수 있어 매우 경제적이다.In addition, there is an advantage that can be easily removed from the aqueous hydrochloric acid solution to remove the silane compound introduced to protect the OH group after the reaction of the compound represented by the general formula (III) protected with silane and solanesil bromide. When using this method, the purification process is very simple because almost no impurities are produced in the preparation of ubiquinone as the final target, and it is very economical because the product can be manufactured in high yield and high purity without using the purification method of chromatography. .

본 발명은 다음 일반식(Ⅲ)으로 표시되는 유비퀴논 제조용 중간체 화합물과 다음 일반식(Ⅱ) 및 (Ⅲ)로 표시되는 유비퀴논 제조용 새로운 중간체 화합물의 제조방법에 관한 것이다. The present invention relates to an intermediate compound for producing ubiquinone represented by the following general formula (III) and a method for producing a new intermediate compound for producing ubiquinone represented by the following general formulas (II) and (III).

Figure 112005065891716-pat00011
Figure 112005065891716-pat00011

Figure 112005065891716-pat00012
Figure 112005065891716-pat00012

구체적으로는 상기 일반식(Ⅳ) 또는 (Ⅴ)로 표시되는 파라-하이드로퀴논 화합물에서 -OH기가 실릴화합물로 보호된 유비퀴논 제조용 중간체 화합물에 관한 것이다.Specifically, the present invention relates to an intermediate compound for preparing ubiquinone in which a -OH group is protected by a silyl compound in the para-hydroquinone compound represented by the general formula (IV) or (V).

본 발명에서 실릴화합물들의 하이드로퀴논의 -OH기를 보호하는데 트리메틸클로로실란, 헥사메틸디실라잔, N,O-비스(트리메틸실릴)아세트아미드 등의 실란 화합물을 염화메틸렌, 1,2-디클로로에탄, 아세토니트릴등의 유기용매속에서 25-80℃에서 반응시키면 95%이상의 수율로 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)톨루엔, 6-브롬-3,4-디메톡시-2,5-비스(트리메틸실릴옥시)톨루엔, 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(이소프레닐-4-벤젠설포닐)톨루엔과 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(데카프레닐-4-벤젠설포닐)톨루엔 화합물들을 제조하였다.In the present invention, silane compounds such as trimethylchlorosilane, hexamethyldisilazane, N, O -bis (trimethylsilyl) acetamide, and the like may be used to protect the -OH group of the hydroquinone of the silyl compounds, such as methylene chloride, 1,2-dichloroethane, When reacted at 25-80 ° C. in an organic solvent such as acetonitrile, 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) toluene, 6-bromine-3,4-dimethoxy- 2,5-bis (trimethylsilyloxy) toluene, 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (isoprenyl-4-benzenesulfonyl) toluene and 3,4-dimeth The oxy-2,5-bis (trimethylsilyloxy) -6- (decaprenyl-4-benzenesulfonyl) toluene compounds were prepared.

또한, 보호기를 제거하는데 묽은 산성수용액에서 짧은 시간에 완전히 제거되 므로 이 과정의 수율 역시 95%이상으로 수율로 유비퀴논을 제조하는데 제조 경비를 낮추는 유용한 제조방법이다. 이하 실시예를 들어 본 발명을 구체적으로 설명한다.In addition, since the removal of the protecting group is completely removed in a dilute acidic aqueous solution in a short time, the yield of this process is also a useful manufacturing method to lower the manufacturing cost to produce the ubiquinone in a yield of more than 95%. The present invention will be described in detail with reference to the following Examples.

본 발명의 제조방법의 반응식은 다음과 같다.The reaction scheme of the production method of the present invention is as follows.

Figure 112005065891716-pat00013
Figure 112005065891716-pat00013

상기 구조식들에서 R은 알킬 또는 알콕시기이다.R in the above formulas is an alkyl or alkoxy group.

[실시예 1] Example 1

<3,4-디메톡시-2,5-비스(트리메틸실릴옥시)톨루엔의 제조><Production of 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) toluene>

상기 일반식(Ⅳ)로 표시되는 화합물에 포함되는 2,3-디메톡시-6-메틸-1,4-하 이드록시퀴논(2,3-Dimethoxy-6-methyl-1,4-hydroquinone) 10g을 1,2-디클로로에탄(1,2-dichloroethane) 50㎖에 가하여 완전용해시킨다. 비스(트리메틸실릴)아세트아미드(bis(trimethylsilyl)acetamide, BSA) 32㎖를 가하고 50℃로 올린다. 45-50℃에서 6시간동안 교반하고 온도를 30℃까지 천천히 내린후 H2O 100ml을 가하고 20분간 교반한다. 층분리하여 수층을 제거하고 유기층을 취하여 MgSO4 5g을 가하고 20분간 탈수한다. 여과하고 50℃에서 농축한다. 농축액에 아세톤 50ml을 가하여 상온에서 1시간 교반한다. 0-5℃로 천천히 온도를 내려서 1시간 교반한다. 침전물을 여과하고 아세톤으로 세척한다. 위와 같은 방법으로 백색결정 17g을 얻었다. 분석결과 본실시예에서 얻어진 백색결정이 3,4-디메톡시-2,5-비스(트리메틸실릴)톨루엔임을 확인할 수 있었다.10 g of 2,3-dimethoxy-6-methyl-1,4-hydroxyquinone (2,3-Dimethoxy-6-methyl-1,4-hydroquinone) contained in the compound represented by the general formula (IV) Is dissolved in 50 ml of 1,2-dichloroethane and completely dissolved. 32 ml of bis (trimethylsilyl) acetamide (BSA) is added and raised to 50 ° C. Stir at 45-50 ° C. for 6 hours and slowly lower the temperature to 30 ° C., add 100 ml of H 2 O and stir for 20 minutes. The layers were separated and the aqueous layer was removed. The organic layer was taken, 5 g of MgSO 4 was added, and dehydrated for 20 minutes. Filter and concentrate at 50 ° C. 50 ml of acetone are added to the concentrate, and the mixture is stirred at room temperature for 1 hour. Slowly lower the temperature to 0-5 ° C. and stir for 1 hour. The precipitate is filtered off and washed with acetone. 17g of white crystals were obtained in the same manner as above. As a result, it was confirmed that the white crystal obtained in this example was 3,4-dimethoxy-2,5-bis (trimethylsilyl) toluene.

[실시예 2] Example 2

<6-브롬-3,4-디메톡시-2,5-비스(트리메틸실릴옥시)톨루엔의 제조><Preparation of 6-bromine-3,4-dimethoxy-2,5-bis (trimethylsilyloxy) toluene>

상기 일반식(Ⅳ)로 표시되는 화합물에 포함되는 5-브로모-2,3-디메톡시-6-메틸-1,4-하이드로퀴논(5-Bromo-2,3-dimethoxy-6-methyl-1,4-hydroquinone) 10g을 1,2-디클로로에탄 50㎖에 가하여 완전용해시킨다. 비스(트리메틸실릴)아세트아미드(bis(trimethylsilyl)acetamide, BSA) 30㎖ 를 반응기에 가하고 50℃로 올린다. 45-50℃에서 6시간동안 교반하고 온도를 30℃까지 천천히 내린후 H2O 100ml을 가하고 20분간 교반한다. 층분리하여 수층을 제거하고 유기층을 취하여 MgSO4 5g을 가하 고 20분간 탈수한다. 여과하고 50℃에서 농축한다. 농축액에 에탄올 40ml을 가하여 상온에서 1시간 강교반한다. 0-5℃로 천천히 온도를 내려서 1시간동안 교반한다. 침전물을 여과하고 아세톤으로 세척한다. 위와 같은 방법으로 백색의 결정 15g을 얻었다. 분석결과 본실시예에서 얻어진 백색결정이 3,4-디메톡시-2,5-비스(트리메틸실릴)톨루엔임을 확인할 수 있었다.5-Bromo-2,3-dimethoxy-6-methyl-1,4-hydroquinone (5-Bromo-2,3-dimethoxy-6-methyl- contained in the compound represented by the general formula (IV) 10 g of 1,4-hydroquinone) is added to 50 ml of 1,2-dichloroethane and completely dissolved. 30 ml of bis (trimethylsilyl) acetamide (BSA) was added to the reactor and raised to 50 ° C. Stir at 45-50 ° C. for 6 hours and slowly lower the temperature to 30 ° C., add 100 ml of H 2 O and stir for 20 minutes. The layers were separated and the aqueous layer was removed. The organic layer was taken, 5 g of MgSO 4 was added, and dehydrated for 20 minutes. Filter and concentrate at 50 ° C. 40 ml of ethanol was added to the concentrate, and stirred at room temperature for 1 hour. Slowly lower the temperature to 0-5 ° C. and stir for 1 hour. The precipitate is filtered off and washed with acetone. In the same manner as above, 15 g of white crystals were obtained. As a result, it was confirmed that the white crystal obtained in this example was 3,4-dimethoxy-2,5-bis (trimethylsilyl) toluene.

[실시예 3] Example 3

<3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(이소프레닐-4-벤젠설포닐)톨루엔의 제조><Production of 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (isoprenyl-4-benzenesulfonyl) toluene>

상기 일반식(Ⅴ)로 표시되는 화합물에 포함되는 2,3-디메톡시-6-메틸-5-(이소프레닐-4-벤젠설포닐)-1,4-하이드로퀴논(2,3-dimethoxy-6-methyl-5-(isoprenyl-4- benzenesulfonyl)-1,4-hydroquinone) 10g을 1,2-디클로로에탄 50㎖에 가하여 완전 용해시킨다. 비스(트리메틸실릴)아세트아미드(bis(trimethylsilyl)acetamide, BSA) 30㎖ 를 반응기에 가하고 50℃로 올린다. 45-50℃에서 6시간동안 교반하고 온도를 30℃까지 천천히 내린후 H2O 100ml을 가하고 20분간 교반한다. 층분리하여 수층을 제거하고 유기층을 취하여 MgSO4 5g을 가하고 20분간 탈수한다. 여과하고 50℃에서 농축한다. 농축액에 에탄올 40ml을 가하여 상온에서 1시간 강교반한다. 0-5℃로 천천히 온도를 내려서 1시간동안 교반한다. 침전물을 여과하고 아세톤으로 세척한다. 위와 같은 방법으로 백색의 결정 13g을 얻었다. 분석결과 본 실시예에서 얻 어진 백색결정이 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(이소프레닐-4-벤젠설포닐)톨루엔임을 확인할 수 있었다.2,3-dimethoxy-6-methyl-5- (isoprenyl-4-benzenesulfonyl) -1,4-hydroquinone (2,3-dimethoxy contained in the compound represented by the general formula (V) 10 g of -6-methyl-5- (isoprenyl-4-benzenesulfonyl) -1,4-hydroquinone) is added to 50 ml of 1,2-dichloroethane and completely dissolved. 30 ml of bis (trimethylsilyl) acetamide (BSA) was added to the reactor and raised to 50 ° C. Stir at 45-50 ° C. for 6 hours and slowly lower the temperature to 30 ° C., add 100 ml of H 2 O and stir for 20 minutes. The layers were separated and the aqueous layer was removed. The organic layer was taken, 5 g of MgSO 4 was added, and dehydrated for 20 minutes. Filter and concentrate at 50 ° C. 40 ml of ethanol was added to the concentrate, and stirred at room temperature for 1 hour. Slowly lower the temperature to 0-5 ° C. and stir for 1 hour. The precipitate is filtered off and washed with acetone. In the same manner as above, 13 g of white crystals were obtained. As a result, it was confirmed that the white crystal obtained in this Example was 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (isoprenyl-4-benzenesulfonyl) toluene.

[실시예 4]Example 4

<3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(이소프레닐-4-벤젠설포닐)톨루엔의 제조><Production of 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (isoprenyl-4-benzenesulfonyl) toluene>

상기 일반식(Ⅳ)로 표시되는 화합물에 포함되는 6-브로모-3,4-디메톡시-2,5-비스(트리메틸실릴옥시)톨루엔(6-bromo-3,4-dimethoxy-2,5-bis (trimethylsilyloxy )toluene) 10g을 테트라하이드로퓨란 100㎖에 용해시킨후 Mg turning 0.65g을 가하여 40℃에서 2.5시간 반응하여 그리나드(grignard) 시약을 제조한후 붕화동〔copper bromide(Ⅰ)〕 3.3 g을 가하고 30분간 교반한다. (E)-4-클로로-2-메틸-1-페닐설포닐-2-부텐((E)-4-chloro-2-methyl-1-phenyl- sulfonyl-2-butene) 2.8g을 테트라하이드로퓨란 100ml에 용해시킨 용액에 0℃ 이상에서 적가하고 2시간동안 교반한다. 디에틸 에테르 300 ml를 가하고 포화 염화암모늄 용액 50ml를 가하여 10분간 교반하고 층분리한다. 수층에 디에틸 에테르 150 ml를 가하여 재추출 한다. 층분리하여 수층을 제거하고 에테르층을 취하여 합하고 MgSO4 5 g으로 10분간 탈수하고 여과한다. 여액을 농축하고 에탄올 15 ml를 가하여 완전용해시킨다. 천천히 온도를 -5℃까지 낮추고 1시간동안 교반하고 침전물을 여과한다. 위와 같은 방법으로 실험시 노란빛을 띄는 백색 결정 13g을 얻을 수 있다. 분석결과 본실시예에서 얻어진 백색결정이 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(이소프레닐-4-벤젠설포닐)톨루엔임을 확인할 수 있었다.6-bromo-3,4-dimethoxy-2,5-bis (trimethylsilyloxy) toluene (6-bromo-3,4-dimethoxy-2,5 contained in the compound represented by the general formula (IV) After dissolving 10 g of -bis (trimethylsilyloxy) toluene) in 100 ml of tetrahydrofuran and adding 0.65 g of Mg turning to react for 2.5 hours at 40 ° C. to prepare a Grignard reagent, copper bromide (Ⅰ) Add 3.3 g and stir for 30 minutes. ( E ) -4-chloro-2-methyl-1-phenylsulfonyl-2-butene (( E ) -4-chloro-2-methyl-1-phenyl- sulfonyl-2-butene) 2.8 g of tetrahydrofuran To the solution dissolved in 100 ml was added dropwise at 0 ℃ or more and stirred for 2 hours. 300 ml of diethyl ether are added, 50 ml of saturated ammonium chloride solution is added, stirred for 10 minutes, and the layers are separated. 150 ml of diethyl ether is added to the aqueous layer and extracted again. The layers were separated, the aqueous layer was removed, the ether layers were combined, combined and dehydrated with 5 g of MgSO 4 for 10 minutes and filtered. Concentrate the filtrate and dissolve completely by adding 15 ml of ethanol. Slowly lower the temperature to -5 ° C, stir for 1 hour and filter the precipitate. In the same way as above, 13g of yellowish white crystals can be obtained. As a result of the analysis, it was confirmed that the white crystals obtained in this example were 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (isoprenyl-4-benzenesulfonyl) toluene.

[실시예 5] Example 5

<3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(데카프레닐-4-벤젠설포닐)톨루엔의 제조><Production of 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (decaprenyl-4-benzenesulfonyl) toluene>

상기 일반식(Ⅴ)로 표시되는 화합물에 포함되는 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(데카프레닐-4-벤젠설포닐)톨루엔 10 g 을 반응기에 가하고 테트라하이드로퓨란 200 ㎖를 가하여 완전용해한다. 솔라네실 브로마이드(solanesyl bromide) 10g을 가하여 용해시킨다. 온도를 -50℃로 맞춘후 포타시움-t-부톡사이드(potassium tert-butoxide) 2.6 g을 -45℃이하에서 가한다. -45-50℃에서 1시간 교반후 에틸 아세테이트 100ml를 가한다. 온도가 -15~-20℃가 되면 H2O 200ml에 염화암모늄 8g을 용해시킨 용액을 가한다. 온도를 올려서 20℃에서 30분간 교반한다. 층분리하여 수층을 제거하고 유기층을 취하여 유기층에 MgSO4 10g을 가하고 20분간 탈수한다. 여과하고 50℃에서 농축한다. 농축액에 헥산 150ml와 아세토니티릴 75ml을 가하고 30분간 교반하고 층분리한다. 하층인 아세토니트릴층에 헥산 150ml를 가하여 재추출한다. 헥산층을 취하고 합하여 농축한다. 위와 같은 방법으로 실험시 오일(oil)형의 노란색 농축액 20g을 얻을 수 있다. 분석결과 본실시예에서 얻어진 농축액이 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(데카프레닐-4-벤젠설포닐) 톨루엔임을 확인할 수 있었다.10 g of 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (decaprenyl-4-benzenesulfonyl) toluene contained in the compound represented by the above general formula (V) was added to the reactor. Add 200 ml of tetrahydrofuran and dissolve completely. 10 g of solanesyl bromide is added to dissolve. Align the temperature at -50 ℃ potassium - exerts a butoxide (potassium tert -butoxide) 2.6 g below -45 ℃ - t. After stirring at −45-50 ° C. for 1 hour, 100 ml of ethyl acetate was added. When the temperature reaches -15 ~ -20 ℃, add a solution of 8g of ammonium chloride to 200ml of H 2 O. The temperature is raised and stirred at 20 ° C. for 30 minutes. The layers were separated, the aqueous layer was removed, the organic layer was taken, 10 g of MgSO 4 was added to the organic layer, and dehydrated for 20 minutes. Filter and concentrate at 50 ° C. 150 ml of hexane and 75 ml of acetonitrile were added to the concentrate, stirred for 30 minutes, and the layers separated. 150 ml of hexane is added to the lower layer of acetonitrile and reextracted. Take the hexane layer, combine and concentrate. In the same way as above, 20g of an oil-based yellow concentrate can be obtained. As a result of the analysis, it was confirmed that the concentrate obtained in the present example was 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (decaprenyl-4-benzenesulfonyl) toluene.

[실시예 6]Example 6

<유비퀴논(Coenzyme Q10)의 제조><Production of Ubiquinone (Coenzyme Q10)>

상기 일반식(Ⅲ)으로 표시되는 화합물에 포함되는 3,4-디메톡시-2,5-비스(트리메틸실릴옥시)-6-(데카프레닐-4-벤젠설포닐)톨루엔 농축액 10 g을 테트라하이드로퓨란 20ml에 용해시킨 용액을 0-5℃의 수퍼하이드라이드(Superhydride) 30ml에 천천히 적가한다. 0-5℃에서 [1,2-비스(디페닐포스피노)에탄] 팔라듐(Ⅱ) 디클로라이드([1,2-bis(diphenylphosphino) ethane] palladium(Ⅱ) dichloride)를 가하고 10분간 교반한다. 온도를 40-45℃로 올려서 14시간 이상 반응한다. 헥산 100ml, 이소푸로필알콜 50ml와 H2O 100ml를 가하여 30분간 교반한다. 층분리하여 수층을 제거하고 유기층을 취하여 염산 5ml와 이소프로필알콜 25ml를 가하고 2시간 교반한다. H2O 100ml을 가하고 10분간 교반 후 층분리한다. 층분리하여 수층을 제거하고 유기층을 취하여 유기층에 MgSO4 10g을 가하고 20분간 탈수한다. 여액을 완전농축하고 농축액에 헥산 30ml을 가하고 에탄올 30ml를 가하여 용해한 후 염화동(copper chloride(Ⅱ) dihydrate) 6g을 가한다. 염산 5ml를 가하고 2시간 교반한다. H2O 50ml를 가하고 10분간 교반 후 층분리하여 수층을 제거하고 유기층을 취하여 유기층에 MgSO4 10g을 가하고 20분간 탈수한다. 여과하여 여액을 농축하고 에탄올 50ml 를 가한 후 상온에서 1시간 교반하고 0-5℃에서 1시간 교반한 후 여과한다. 이 결정을 이소푸로필 알콜중에서 재 결정하면 주황색 결정의 유비퀴논 7.1g을 얻을 수 있다. 10 g of 3,4-dimethoxy-2,5-bis (trimethylsilyloxy) -6- (decaprenyl-4-benzenesulfonyl) toluene concentrate contained in the compound represented by the above general formula (III) The solution dissolved in 20 ml of hydrofuran is slowly added dropwise to 30 ml of superhydride at 0-5 ° C. At 0-5 ° C. [1,2-bis (diphenylphosphino) ethane] palladium (II) dichloride ([1,2-bis (diphenylphosphino) ethane] palladium (II) dichloride) is added and stirred for 10 minutes. The temperature is raised to 40-45 ° C. and reacted for at least 14 hours. 100 ml of hexane, 50 ml of isoprophyl alcohol and 100 ml of H 2 O were added and stirred for 30 minutes. The layers were separated, the aqueous layer was removed, the organic layer was taken, 5 ml of hydrochloric acid and 25 ml of isopropyl alcohol were added, followed by stirring for 2 hours. 100 ml of H 2 O was added thereto, stirred for 10 minutes, and the layers were separated. The layers were separated, the aqueous layer was removed, the organic layer was taken, 10 g of MgSO 4 was added to the organic layer, and dehydrated for 20 minutes. The filtrate is completely concentrated, 30 ml of hexane is added to the concentrate, 30 ml of ethanol is dissolved, and 6 g of copper chloride (II) dihydrate is added thereto. 5 ml of hydrochloric acid is added and stirred for 2 hours. 50 ml of H 2 O was added thereto, stirred for 10 minutes, the layers were separated, the aqueous layer was removed, an organic layer was taken, 10 g of MgSO 4 was added to the organic layer, and dehydrated for 20 minutes. Filtrate was concentrated, filtrate was added 50ml of ethanol, and stirred at room temperature for 1 hour, and stirred at 0-5 ° C for 1 hour and filtered. Recrystallization of this crystal in isoprophyll alcohol yields 7.1 g of orange crystal ubiquinone.

본 발명의 유비퀴논 제조용 중간체 화합물들은 낮은 비용으로 제조가 가능하며, 간단한 방법으로 유비퀴논을 제조하는데 유용하게 이용될 수 있는 효과를 갖는다.The intermediate compounds for preparing ubiquinone of the present invention can be prepared at low cost, and have an effect that can be usefully used to prepare ubiquinone in a simple manner.

Claims (4)

삭제delete 다음 일반식(Ⅲ)로 표시되는 유비퀴논 제조용 중간체 화합물.An intermediate compound for producing ubiquinone represented by the following general formula (III).
Figure 112005065891716-pat00015
Figure 112005065891716-pat00015
상기식에서 R은 알킬 또는 알콕시기이며, Y는 수소, 벤젠설포닐 또는 톨루엔 설포닐이고 n은 0∼9의 정수이다. Wherein R is an alkyl or alkoxy group, Y is hydrogen, benzenesulfonyl or toluene sulfonyl and n is an integer from 0 to 9.
다음 일반식(Ⅳ) 또는 일반식(Ⅴ)로 표시되는 화합물을 유기극성용매중에서 실릴화합물과 반응시켜 일반식(Ⅳ) 또는 일반식(Ⅴ)로 표시되는 화합물에서 하이드로퀴논의 -OH기를 실릴화합물로 보호시킨 다음 일반식(Ⅱ) 또는 일반식(Ⅲ)으로 표시되는 화합물을 제조하는 방법.The following compound represented by the general formula (IV) or (V) is reacted with a silyl compound in an organic polar solvent to compound -OH group of the hydroquinone in the compound represented by the general formula (IV) or (V). Method for preparing a compound represented by the general formula (II) or formula (III) after protecting with.
Figure 112006084499611-pat00017
Figure 112006084499611-pat00017
상기식에서 R은 알킬 또는 알콕시기이며 Z는 수소, 할로겐이다.Wherein R is an alkyl or alkoxy group and Z is hydrogen, halogen.
Figure 112006084499611-pat00018
Figure 112006084499611-pat00018
상기식에서 R은 알킬 또는 알콕시기이며, Y는 수소, 벤젠설포닐 또는 톨루엔 설포닐이고 n은 0∼9의 정수이다.Wherein R is an alkyl or alkoxy group, Y is hydrogen, benzenesulfonyl or toluene sulfonyl and n is an integer from 0 to 9.
Figure 112006084499611-pat00019
Figure 112006084499611-pat00019
상기식에서 Z는 수소 또는 할로겐이다.In which Z is hydrogen or halogen.
Figure 112006084499611-pat00020
Figure 112006084499611-pat00020
상기식에서 Y는 수소, 벤젠설포닐 또는 톨루엔설포닐이고 n은 0~9의 정수이다.Wherein Y is hydrogen, benzenesulfonyl or toluenesulfonyl and n is an integer of 0-9.
제3항에 있어서,The method of claim 3, 유기극성용매가 염화메틸렌 1,2-디클로로에탄, 아세토니트릴 또는 디메틸포름아마이드 중에서 선택되는 것이고 실릴화합물이 트리메틸클로로 실란, 헥사메틸디실라잔, 또는 N,0-비스(트리메틸실릴)아세트아마이드 중에서 선택되는 일반식(Ⅱ) 또는 일반식(Ⅲ)으로 표시되는 화합물의 제조방법.The organic polar solvent is selected from methylene chloride 1,2-dichloroethane, acetonitrile or dimethylformamide and the silyl compound is selected from trimethylchloro silane, hexamethyldisilazane, or N, 0 -bis (trimethylsilyl) acetamide Method for producing a compound represented by formula (II) or (III).
KR1020050109623A 2005-11-16 2005-11-16 Intermediate compound for ubiquinone and manufacturing method of the same KR100690240B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020050109623A KR100690240B1 (en) 2005-11-16 2005-11-16 Intermediate compound for ubiquinone and manufacturing method of the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050109623A KR100690240B1 (en) 2005-11-16 2005-11-16 Intermediate compound for ubiquinone and manufacturing method of the same

Publications (1)

Publication Number Publication Date
KR100690240B1 true KR100690240B1 (en) 2007-03-12

Family

ID=38102537

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050109623A KR100690240B1 (en) 2005-11-16 2005-11-16 Intermediate compound for ubiquinone and manufacturing method of the same

Country Status (1)

Country Link
KR (1) KR100690240B1 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Angewandte Chemie, Int. Ed. Engl., 1992, 31(3), 31*
Org. Lett., 2000, 2(23), 3671-3673. *

Similar Documents

Publication Publication Date Title
CA1145761A (en) Quinone derivatives
JP4351689B2 (en) Method for producing N, N&#39;-disubstituted p-quinonediimine, stabilizer comprising the diamine, organobrown composition, method for stabilizing the same, and phase transfer catalyst method
CN111484524B (en) Vitamin A acetate intermediate C15 and preparation method of vitamin A acetate
CN111484400B (en) Preparation method of 2-methyl-4- (2,6, 6-trimethylcyclohexene-1-yl) -2-butenal
US6448419B1 (en) Synthesis of 2-hydroxyestradiol derivatives
US4582919A (en) Process for the manufacture of optically active compounds
KR100690240B1 (en) Intermediate compound for ubiquinone and manufacturing method of the same
CA2010980C (en) Processes for the preparation of pterin derivatives
CN109776295B (en) Aryl iodine compound containing difluoromethylene at ortho-position and preparation method thereof
EP0168175B1 (en) Preparation of tamoxifen
WO2014131995A1 (en) Method for the enzymatic synthesis of diosmetin derivatives
JPH054981A (en) Hydroquinone derivative
EP1615879B1 (en) Process for the production of 9-cis retinoic acid
KR100514494B1 (en) Synthetic method of the para-hydroquinone compound containing allylic sulfone moiety that can be efficiently utilized for the preparation of coenzyme Q and vitamin K
JP4176201B2 (en) Method for producing 5-halogeno-2-substituted pyridine
EP0178904A2 (en) Quinone synthesis
EP0537954B1 (en) Process of preparing diphenylmethane derivatives
JPH0892151A (en) Production of allylquinone
US6197962B1 (en) Method for producing 2-sulfonylpyridine derivatives and method for producing 2-{[(2-pyridyl)methyl]thio}-1H-benzimidazole derivatives
KR100966027B1 (en) The novel preparation method of decursin and decursin analoges
JPH0967274A (en) Asymmetric diels-alder reaction
JPS6346734B2 (en)
KR20060117430A (en) Process for the preparation of coenzyme qn and intermediates thereof
KR100570279B1 (en) Intermediates of coenzyme qn and process for the preparation thereof
CN103387587A (en) Preparation method for entecavir intermediate

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120221

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee